Unveiling the double-edged sword: SOD1 trimers possess tissue-selective toxicity and bind septin-7 in motor

Esther Sue Choi1, Brianna Hnath2, Congzhou Mike Sha1

  • 1Department of Pharmacology, Penn State College of Medicine, Hershey, PA, USA; Medical Scientist Training Program, Penn State College of Medicine, Hershey, PA, USA.

PubMed

Insights

Misfolded superoxide dismutase 1 (SOD1) trimers, not aggregates, drive cell death in ALS models. This study maps SOD1 trimer interactions in the nervous system and muscle, revealing new disease mechanisms.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Misfolded superoxide dismutase 1 (SOD1) species are implicated in amyotrophic lateral sclerosis (ALS) pathogenesis.
  • Structurally independent SOD1 trimers, distinct from insoluble aggregates, are linked to increased cellular toxicity in ALS models.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying SOD1 trimer-induced cellular toxicity.
  • To identify tissue-selective protein interactors and pathways affected by SOD1 trimers in the central nervous system and skeletal muscle.

Main Methods:

  • Proteomics to map the SOD1 trimer interactome in brain, spinal cord, and skeletal muscle.
  • Computational and biochemical analyses to characterize SOD1 trimer-protein binding, including interactions with septin-7.
  • Gene enrichment analysis to identify affected cellular pathways.

Main Results:

  • Identified a map of potential tissue-selective protein-binding partners for SOD1 trimers.
  • Found that SOD1 trimers may disrupt normal cellular functions, including dendritic spine morphogenesis and synaptic function in the CNS, and cellular metabolism in skeletal muscle.
  • Discovered SOD1 trimer-selective gene enrichment and characterized specific protein interactions, such as with septin-7.

Conclusions:

  • SOD1 trimers interact with distinct proteins and pathways in a tissue-selective manner, offering insights into ALS pathology.
  • These interactions suggest a convergence of genetic and pathophysiological mechanisms in ALS involving SOD1 trimers.
  • The findings highlight potential therapeutic targets by revealing key proteins and pathways affected by SOD1 trimers.